InProcess LSP
Headquartered in Oss, the Netherlands, InProcess-LSP is a pioneer in Process Analytical Technology (PAT) solutions. Since its founding in 2014, the company has grown rapidly, driven by its groundbreaking innovation—the NanoFlowSizer.
With extensive expertise in PAT and nanoparticle characterization, InProcess-LSP addresses the industry’s increasing need for complete quality control in pharmaceutical production. The company supports leading pharmaceutical manufacturers, including producers of COVID-19 vaccines, in developing and monitoring complex medicines and vaccines. Many of these products contain nanoparticles, where particle size plays a critical role in ensuring safety, stability, and efficacy.
As the inventors of the NanoFlowSizer, InProcess-LSP introduced the first and only instrument capable of real-time, non-invasive nanoparticle size measurement in flow—even in highly turbid suspensions. This unique technology enables continuous, in-process analysis within seconds, eliminating the need for time-consuming sample preparation.
By providing companies with real-time insights into nanoparticle size and distribution, InProcess-LSP helps ensure robust manufacturing processes and high-quality pharmaceutical products.
